True, but here is my question for you based on tha
Post# of 148181
Is CYDY better off getting all of its ducks in a row (BTD's, BLA, approvals, etc) and THEN looking to move the whole enchilada, or make deals indication by indication? The latter sounds like A LOT more work and is far more labor intensive.
Maybe they close a deal for that $100MM in non-dilutive financing, move forward with NASH and GvHD trials, get their BTS's and approvals and look to either partner or get BO from one BP. That, to me would be what appears to make the most sense.
Open to other opinions and thoughts...